J&J Seeks India’s Permission For Phase 3 Trial Of 1-Shot Vaccine: Report

Multinational pharma giant Johnson & Johnson has applied to India’s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import…